Graham G, Xiao YYK, Rappoport D, Siddiqi S. Population-level differences in revascularization treatment and outcomes among various United States subpopulations. World J Cardiol 2016; 8(1): 24-40 [PMID: 26839655 DOI: 10.4330/wjc.v8.i1.24]
Corresponding Author of This Article
Garth Graham, MD, MPH, President, Associate Clinical Professor of Medicine, Aetna Foundation, Hartford, 151 Farmington Avenue, Hartford, CT 06510, United States. ggraham@gmail.com
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Jan 26, 2016; 8(1): 24-40 Published online Jan 26, 2016. doi: 10.4330/wjc.v8.i1.24
Population-level differences in revascularization treatment and outcomes among various United States subpopulations
Garth Graham, Yang-Yu Karen Xiao, Dan Rappoport, Saima Siddiqi
Garth Graham, Yang-Yu Karen Xiao, Dan Rappoport, University of Connecticut School of Medicine, Farmington, CT 06030, United States
Garth Graham, Saima Siddiqi, Aetna Foundation, Hartford, CT 06510, United States
Author contributions: All authors contributed to this manuscript.
Conflict-of-interest statement: The authors have no conflict of interest related to this manuscript.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Garth Graham, MD, MPH, President, Associate Clinical Professor of Medicine, Aetna Foundation, Hartford, 151 Farmington Avenue, Hartford, CT 06510, United States. ggraham@gmail.com
Telephone: +1-860-2732645
Received: May 29, 2015 Peer-review started: May 31, 2015 First decision: August 25, 2015 Revised: October 12, 2015 Accepted: November 3, 2015 Article in press: November 4, 2015 Published online: January 26, 2016 Processing time: 237 Days and 9.9 Hours
Core Tip
Core tip: Disparities persist in the care of myocardial infarction (MI) in women and racial/ethnic minorities in the United States. They arrive at the hospital later, present with more risk factors and co-morbidities, and are less likely to receive guideline treatments. Women and blacks are less likely to receive revascularization. Younger women have more in-hospital mortality, and both blacks and women have greater long-term risk for death, recurrent MI, and re-hospitalization. Disparities in risk factors and co-morbidities among Hispanics/Latinos are complicated by the many subgroups. American Indians/Alaska Natives and Asian subpopulations have been much less studied, but surveillance data indicate more risk factors and co-morbidities among these subgroups.
